Details of the Drug Formulaction

General Information of Drug Formulation (ID: F05271)

Formulation Name

Dasatinib 140 mg tablet

Company

E.R. Squibb & Sons

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	Status
Dasatinib	DMJV2EK	Blast phase chronic myelogenous leukemia, BCR-ABL1 positive	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	E00625	Not Available	Disintegrant
Lactose monohydrate	E00393	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	E00208	11177	lubricant
Titanium dioxide	E00322	26042	Coating agent; Colorant; Opacifying agent

--------------------